Società Vinings Holdings Inc. Other OTC
Azioni
NDYN
US92744A1051
Prodotti farmaceutici
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Brian Cogley
DFI | Director of Finance/CFO | 38 | 17/05/23 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Colleen Delaney
CTO | Chief Tech/Sci/R&D Officer | 57 | 30/08/23 |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 62 | 28/10/22 | |
Director/Board Member | 55 | 28/10/22 | |
Christine Sheehy
CMP | Compliance Officer | 57 | 28/10/22 |
Gene Salkind
BRD | Director/Board Member | 70 | 28/10/22 |
Chris Calise
BRD | Director/Board Member | 51 | 28/10/22 |
David Mehalick
CEO | Chief Executive Officer | 56 | 28/10/22 |
Daniel Yerace
COO | Chief Operating Officer | 41 | 28/10/22 |
Director/Board Member | 56 | 28/10/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 37 118 593 | 25 373 891 ( 68,36 %) | 0 | 68,36 % |
Coordinate società
Coeptis Therapeutics Holdings, Inc.
105 Bradford Road Suite 420
15090, Wexford
+
http://www.coeptistx.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+51,69% | 798 Mrd | |
+41,51% | 633 Mrd | |
-5,06% | 356 Mrd | |
+19,24% | 328 Mrd | |
+9,84% | 304 Mrd | |
+17,66% | 244 Mrd | |
+3,39% | 227 Mrd | |
+10,75% | 216 Mrd | |
+7,59% | 166 Mrd |